Stelvio Therapeutics joins JLABS San Diego

September 26, 2017 marked the day Stelvio joined Johnson & Johnson Innovation JLABS in San Diego, California. This vibrant ecosystem is a catalyst for innovation with a capital efficient no strings attached business model. This enables Stelvio to focus on it's mission to deliver innovative medicines of value to patients and being a resident of JLABS provides exposure to key deal makers for R&D collaborations.


Stelvio presenting at Enzymes in Drug Discovery Summit on February 23, 2018 in San Diego

Alexey Terskikh, PhD, Chief Scientific Officer of Stelvio will be presenting in the track titled "Epigenetic Enzymes in Drug discovery" and in the session "Epigenetic Modification & Transcriptional Regulation." For more information, please visit the conference website:

This site is in no way affiliated with or endorsed by specified business. It exists as a compendium of supporting information intended for informational purposes only. If you want to buy this website, please don't hesitate to contact us via e-mail: domain (dot) sales (dot) org @ gmail (dot) com or you can find and buy it on Afternic domain auctions.